FDA Drug Application (090753) for SUMATRIPTAN; NAPROXEN SODIUM by PAR PHARM

Back to FDA Applications sponsored by PAR PHARM

Application Number090753
Product Number001
FormTABLET; ORAL
Dosage85MG; 500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUMATRIPTAN; NAPROXEN SODIUM
Active IngredientSUMATRIPTAN; NAPROXEN SODIUM



Back to FDA Applications sponsored by PAR PHARM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.